← FDA Drug Approvals (Drugs@FDA)

HYDROCHLOROTHIAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2026-10-07

Drug application

FDA Application #

ANDA218248

Application type

Abbreviated New Drug Application (Generic)

Brand name

HYDROCHLOROTHIAZIDE

Generic name

Hydrochlorothiazide

Active ingredients

HYDROCHLOROTHIAZIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

RUBICON RESEARCH

First approval

2026-10-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown